Vol 7: Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible.Report as inadecuate



 Vol 7: Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible.


Vol 7: Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 7: Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible.
This article is from BMC Research Notes, volume 7.AbstractBackground: Brain metastases (BMs) are common in melanoma patients. Adjuvant whole brain radiotherapy (WBRT) following local treatment of intracranial melanoma metastases with neurosurgery and-or stereotactic radiosurgery is controversial. A randomised trial is needed. However, accrual to WB

Author: Fogarty, Gerald B; Hong, Angela; Jacobsen, Kari Dolven; Reisse, Claudius H; Shivalingam, Brindha; Burmeister, Bryan; Haydu, Lauren E; Paton, Elizabeth

Source: https://archive.org/



DOWNLOAD PDF




Related documents